Update on Expanded Indications for NOACs Beyond Stroke Prevention
Atrial Fibrillation Coronary Artery Disease Deep Vein Thrombosis General News Thromboembolism Thrombosis

Update on Expanded Indications for NOACs Beyond Stroke Prevention

Since their first approval, nonvitamin K antagonist oral anticoagulants (NOACs; also known as direct oral anticoagulants or DOACs) have become a common treatment for stroke prophylaxis in patients with nonvalvular atrial fibrillation (NVAF).1 Current US…